Patterns of Recurrence, Long-term Survival and Toxicity Analysis of Endometrial Adenocarcinoma Patients Reclassified Under the Recent ESMO-ESGO-ESTRO Stratification: Seven-Year Results From a Single Institution
Conclusions
Recurrence rates, survival rates, and the patterns of recurrence are comparable with published literature and partly validates the ESMO-ESGO-ESTRO consensus statement. Addition of EBRT significantly increases risk of late proctitis as compared with VBT alone.
Source: International Journal of Gynecological Cancer - Category: Cancer & Oncology Tags: Uterine Cancer Source Type: research
More News: Adenocarcinoma | Brachytherapy | Cancer | Cancer & Oncology | Cancer of the Uterus | Cystitis | Endometrial Cancer | External Beam Therapy | Hysterectomy | MRI Scan | OBGYN | Study | Toxicology